Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Stomatal development in Arabidopsis.

The arabidopsis book

Pillitteri LJ, Dong J.
PMID: 23864836
Arabidopsis Book. 2013 Jun 06;11:e0162. doi: 10.1199/tab.0162. Print 2013.

Stomata consist of two guard cells that function as turgor-operated valves that regulate gas exchange in plants. In Arabidopsis, a dedicated cell lineage is initiated and undergoes a series of cell divisions and cell-state transitions to produce a stoma....

Cite
Pillitteri LJ, Dong J. Stomatal development in Arabidopsis. Arabidopsis Book. 2013;11:e0162doi: 10.1199/tab.0162.
Pillitteri, L. J., & Dong, J. (2013). Stomatal development in Arabidopsis. The arabidopsis book, 11e0162. https://doi.org/10.1199/tab.0162
Pillitteri, Lynn Jo, and Dong, Juan. "Stomatal development in Arabidopsis." The arabidopsis book vol. 11 (2013): e0162. doi: https://doi.org/10.1199/tab.0162
Pillitteri LJ, Dong J. Stomatal development in Arabidopsis. Arabidopsis Book. 2013 Jun 06;11:e0162. doi: 10.1199/tab.0162. Print 2013. PMID: 23864836; PMCID: PMC3711358.
Copy Download .nbib Format: NLM
Severe transverse discrepancy in adult Class III patient: Parallel rapid palatal expansion with a bone-borne tandem expansion screws (TSE) followed by lingual fixed appliance for a non-surgical treatment: A case report.

International orthodontics

Cremonini F, Ansaloni MC, Cremonini A, Maino BG, Paoletto E, Pellitteri F, Lombardo L.
PMID: 34872832
Int Orthod. 2021 Dec 03; doi: 10.1016/j.ortho.2021.11.001. Epub 2021 Dec 03.

INTRODUCTION: Midpalatal suture opening in young adults is often difficult to achieve, depending on the suture maturation stage. It has been suggested that it is possible to avoid surgery and still achieve a successful pure skeletal expansion if a...

Cite
Cremonini F, Ansaloni MC, Cremonini A, et al. Severe transverse discrepancy in adult Class III patient: Parallel rapid palatal expansion with a bone-borne tandem expansion screws (TSE) followed by lingual fixed appliance for a non-surgical treatment: A case report. Int Orthod. 2021;doi: 10.1016/j.ortho.2021.11.001.
Cremonini, F., Ansaloni, M. C., Cremonini, A., Maino, B. G., Paoletto, E., Pellitteri, F., & Lombardo, L. (2021). Severe transverse discrepancy in adult Class III patient: Parallel rapid palatal expansion with a bone-borne tandem expansion screws (TSE) followed by lingual fixed appliance for a non-surgical treatment: A case report. International orthodontics, . https://doi.org/10.1016/j.ortho.2021.11.001
Cremonini, Francesca, et al. "Severe transverse discrepancy in adult Class III patient: Parallel rapid palatal expansion with a bone-borne tandem expansion screws (TSE) followed by lingual fixed appliance for a non-surgical treatment: A case report." International orthodontics vol. (2021). doi: https://doi.org/10.1016/j.ortho.2021.11.001
Cremonini F, Ansaloni MC, Cremonini A, Maino BG, Paoletto E, Pellitteri F, Lombardo L. Severe transverse discrepancy in adult Class III patient: Parallel rapid palatal expansion with a bone-borne tandem expansion screws (TSE) followed by lingual fixed appliance for a non-surgical treatment: A case report. Int Orthod. 2021 Dec 03; doi: 10.1016/j.ortho.2021.11.001. Epub 2021 Dec 03. PMID: 34872832.
Copy Download .nbib Format: NLM
Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature.

Annals of translational medicine

Gabr JB, Liu E, Mian S, Pillittere J, Bonilla E, Banki K, Perl A.
PMID: 32793731
Ann Transl Med. 2020 Jul;8(14):887. doi: 10.21037/atm-20-3127.

Here, we present a 22-year-old female patient with adult-onset Still's disease (AOSD) who was newly diagnosed in the setting of secondary macrophage activation syndrome (MAS), a rare, life-threatening inflammatory disease with 50% mortality due to multi-organ failure. She met...

Cite
Gabr JB, Liu E, Mian S, et al. Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature. Ann Transl Med. 2020;8(14):887doi: 10.21037/atm-20-3127.
Gabr, J. B., Liu, E., Mian, S., Pillittere, J., Bonilla, E., Banki, K., & Perl, A. (2020). Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature. Annals of translational medicine, 8(14), 887. https://doi.org/10.21037/atm-20-3127
Gabr, Jihad Ben, et al. "Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature." Annals of translational medicine vol. 8,14 (2020): 887. doi: https://doi.org/10.21037/atm-20-3127
Gabr JB, Liu E, Mian S, Pillittere J, Bonilla E, Banki K, Perl A. Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature. Ann Transl Med. 2020 Jul;8(14):887. doi: 10.21037/atm-20-3127. PMID: 32793731; PMCID: PMC7396773.
Copy Download .nbib Format: NLM
Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users.

Addictive behaviors reports

Pillitteri JL, Shiffman S, Sembower MA, Polster MR, Curtin GM.
PMID: 32467843
Addict Behav Rep. 2020 Jan 24;11:100254. doi: 10.1016/j.abrep.2020.100254. eCollection 2020 Jun.

INTRODUCTION: Snus, a low nitrosamine smokeless tobacco product, presents less risks to health than cigarettes. Effectively communicating such risk information could facilitate smokers switching completely to snus, thereby benefiting public health.METHODS: This study assessed comprehension and perceptions of modified-risk...

Cite
Pillitteri JL, Shiffman S, Sembower MA, et al. Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users. Addict Behav Rep. 2020;11:100254doi: 10.1016/j.abrep.2020.100254.
Pillitteri, J. L., Shiffman, S., Sembower, M. A., Polster, M. R., & Curtin, G. M. (2020). Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users. Addictive behaviors reports, 11100254. https://doi.org/10.1016/j.abrep.2020.100254
Pillitteri, Janine L, et al. "Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users." Addictive behaviors reports vol. 11 (2020): 100254. doi: https://doi.org/10.1016/j.abrep.2020.100254
Pillitteri JL, Shiffman S, Sembower MA, Polster MR, Curtin GM. Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users. Addict Behav Rep. 2020 Jan 24;11:100254. doi: 10.1016/j.abrep.2020.100254. eCollection 2020 Jun. PMID: 32467843; PMCID: PMC7244929.
Copy Download .nbib Format: NLM
How size ratio and segregation affect the packing of binary granular mixtures.

Soft matter

Pillitteri S, Opsomer E, Lumay G, Vandewalle N.
PMID: 32914151
Soft Matter. 2020 Sep 11; doi: 10.1039/d0sm00939c. Epub 2020 Sep 11.

For reaching high packing fractions, grains of various sizes are often mixed together allowing the small grains to fill the voids created by the large ones. However, in most cases, granular segregation occurs leading to lower packing fractions. We...

Cite
Pillitteri S, Opsomer E, Lumay G, et al. How size ratio and segregation affect the packing of binary granular mixtures. Soft Matter. 2020;doi: 10.1039/d0sm00939c.
Pillitteri, S., Opsomer, E., Lumay, G., & Vandewalle, N. (2020). How size ratio and segregation affect the packing of binary granular mixtures. Soft matter, . https://doi.org/10.1039/d0sm00939c
Pillitteri, Salvatore, et al. "How size ratio and segregation affect the packing of binary granular mixtures." Soft matter vol. (2020). doi: https://doi.org/10.1039/d0sm00939c
Pillitteri S, Opsomer E, Lumay G, Vandewalle N. How size ratio and segregation affect the packing of binary granular mixtures. Soft Matter. 2020 Sep 11; doi: 10.1039/d0sm00939c. Epub 2020 Sep 11. PMID: 32914151.
Copy Download .nbib Format: NLM
Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis.

Diabetology & metabolic syndrome

Guarnotta V, Vigneri E, Pillitteri G, Ciresi A, Pizzolanti G, Giordano C.
PMID: 29760789
Diabetol Metab Syndr. 2018 May 10;10:40. doi: 10.1186/s13098-018-0341-6. eCollection 2018.

BACKGROUND: Idiopathic type 1 diabetes mellitus (IDM) is characterized by an onset with insulinopenia and ketoacidosis with negative β-cell autoimmunity markers and lack of association with HLA. The aim of the study is to compare the clinical and metabolic...

Cite
Guarnotta V, Vigneri E, Pillitteri G, et al. Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis. Diabetol Metab Syndr. 2018;10:40doi: 10.1186/s13098-018-0341-6.
Guarnotta, V., Vigneri, E., Pillitteri, G., Ciresi, A., Pizzolanti, G., & Giordano, C. (2018). Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis. Diabetology & metabolic syndrome, 1040. https://doi.org/10.1186/s13098-018-0341-6
Guarnotta, Valentina, et al. "Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis." Diabetology & metabolic syndrome vol. 10 (2018): 40. doi: https://doi.org/10.1186/s13098-018-0341-6
Guarnotta V, Vigneri E, Pillitteri G, Ciresi A, Pizzolanti G, Giordano C. Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis. Diabetol Metab Syndr. 2018 May 10;10:40. doi: 10.1186/s13098-018-0341-6. eCollection 2018. PMID: 29760789; PMCID: PMC5944025.
Copy Download .nbib Format: NLM
Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement.

Neurology. Clinical practice

Bax F, Tascini C, Valente M, Marini A, Surcinelli A, Pellitteri G, De Carlo C, Gerussi V, Gigli GL.
PMID: 33842076
Neurol Clin Pract. 2021 Apr;11(2):e92-e96. doi: 10.1212/CPJ.0000000000001029.

OBJECTIVE: To evaluate the prevalence of hyposmia and dysgeusia in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their temporal relationship with the onset of other symptoms.METHODS: We performed a retrospective analysis of patients admitted during...

Cite
Bax F, Tascini C, Valente M, et al. Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement. Neurol Clin Pract. 2021;11(2):e92-e96doi: 10.1212/CPJ.0000000000001029.
Bax, F., Tascini, C., Valente, M., Marini, A., Surcinelli, A., Pellitteri, G., De Carlo, C., Gerussi, V., & Gigli, G. L. (2021). Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement. Neurology. Clinical practice, 11(2), e92-e96. https://doi.org/10.1212/CPJ.0000000000001029
Bax, Francesco, et al. "Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement." Neurology. Clinical practice vol. 11,2 (2021): e92-e96. doi: https://doi.org/10.1212/CPJ.0000000000001029
Bax F, Tascini C, Valente M, Marini A, Surcinelli A, Pellitteri G, De Carlo C, Gerussi V, Gigli GL. Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement. Neurol Clin Pract. 2021 Apr;11(2):e92-e96. doi: 10.1212/CPJ.0000000000001029. PMID: 33842076; PMCID: PMC8032441.
Copy Download .nbib Format: NLM
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.

Gut

Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G.
PMID: 33436496
Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12.

OBJECTIVE: Cancer stem cells are responsible for tumour spreading and relapse. Human epidermal growth factor receptor 2 (HER2) expression is a negative prognostic factor in colorectal cancer (CRC) and a potential target in tumours carrying the gene amplification. Our...

Cite
Mangiapane LR, Nicotra A, Turdo A, et al. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut. 2021;71(1):119-128doi: 10.1136/gutjnl-2020-323553.
Mangiapane, L. R., Nicotra, A., Turdo, A., Gaggianesi, M., Bianca, P., Di Franco, S., Sardina, D. S., Veschi, V., Signore, M., Beyes, S., Fagnocchi, L., Fiori, M. E., Bongiorno, M. R., Lo Iacono, M., Pillitteri, I., Ganduscio, G., Gulotta, G., Medema, J. P., Zippo, A., Todaro, M., De Maria, R., & Stassi, G. (2022). PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut, 71(1), 119-128. https://doi.org/10.1136/gutjnl-2020-323553
Mangiapane, Laura Rosa, et al. "PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells." Gut vol. 71,1 (2022): 119-128. doi: https://doi.org/10.1136/gutjnl-2020-323553
Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12. PMID: 33436496; PMCID: PMC8666826.
Copy Download .nbib Format: NLM
Particle Dynamics at the Onset of the Granular Gas-Liquid Transition.

Physical review letters

Noirhomme M, Cazaubiel A, Falcon E, Fischer D, Garrabos Y, Lecoutre-Chabot C, Mawet S, Opsomer E, Palencia F, Pillitteri S, Vandewalle N.
PMID: 33834798
Phys Rev Lett. 2021 Mar 26;126(12):128002. doi: 10.1103/PhysRevLett.126.128002.

We study experimentally the dynamical behavior of few large tracer particles placed in a quasi-2D granular "gas" made of many small beads in a low-gravity environment. Multiple inelastic collisions transfer momentum from the uniaxially driven gas to the tracers...

Cite
Noirhomme M, Cazaubiel A, Falcon E, et al. Particle Dynamics at the Onset of the Granular Gas-Liquid Transition. Phys Rev Lett. 2021;126(12):128002doi: 10.1103/PhysRevLett.126.128002.
Noirhomme, M., Cazaubiel, A., Falcon, E., Fischer, D., Garrabos, Y., Lecoutre-Chabot, C., Mawet, S., Opsomer, E., Palencia, F., Pillitteri, S., & Vandewalle, N. (2021). Particle Dynamics at the Onset of the Granular Gas-Liquid Transition. Physical review letters, 126(12), 128002. https://doi.org/10.1103/PhysRevLett.126.128002
Noirhomme, M, et al. "Particle Dynamics at the Onset of the Granular Gas-Liquid Transition." Physical review letters vol. 126,12 (2021): 128002. doi: https://doi.org/10.1103/PhysRevLett.126.128002
Noirhomme M, Cazaubiel A, Falcon E, Fischer D, Garrabos Y, Lecoutre-Chabot C, Mawet S, Opsomer E, Palencia F, Pillitteri S, Vandewalle N. Particle Dynamics at the Onset of the Granular Gas-Liquid Transition. Phys Rev Lett. 2021 Mar 26;126(12):128002. doi: 10.1103/PhysRevLett.126.128002. PMID: 33834798.
Copy Download .nbib Format: NLM
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era.

Journal of neurology

Marini A, Vogrig A, Bax F, Pellitteri G, Surcinelli A, Valente M, Gigli GL.
PMID: 32749602
J Neurol. 2021 Apr;268(4):1201-1202. doi: 10.1007/s00415-020-10006-2. Epub 2020 Aug 04.

No abstract available.

Cite
Marini A, Vogrig A, Bax F, et al. Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era. J Neurol. 2020;268(4):1201-1202doi: 10.1007/s00415-020-10006-2.
Marini, A., Vogrig, A., Bax, F., Pellitteri, G., Surcinelli, A., Valente, M., & Gigli, G. L. (2021). Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era. Journal of neurology, 268(4), 1201-1202. https://doi.org/10.1007/s00415-020-10006-2
Marini, Alessandro, et al. "Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era." Journal of neurology vol. 268,4 (2021): 1201-1202. doi: https://doi.org/10.1007/s00415-020-10006-2
Marini A, Vogrig A, Bax F, Pellitteri G, Surcinelli A, Valente M, Gigli GL. Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era. J Neurol. 2021 Apr;268(4):1201-1202. doi: 10.1007/s00415-020-10006-2. Epub 2020 Aug 04. PMID: 32749602; PMCID: PMC7400752.
Copy Download .nbib Format: NLM
Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study.

Journal of endocrinological investigation

Guarnotta V, Pillitteri G, Gambino G, Radellini S, Vigneri E, Pizzolanti G, Giordano C.
PMID: 33099763
J Endocrinol Invest. 2021 Jul;44(7):1387-1394. doi: 10.1007/s40618-020-01421-3. Epub 2020 Oct 24.

PURPOSE: To evaluate factors influencing the insulin and levothyroxine requirement in patients with autoimmune polyglandular syndrome type 3 (APS-3) vs. patients with type 1 diabetes mellitus (T1DM) and autoimmune hypothyroidism (AH) alone, respectively.METHODS: Fifty patients with APS-3, 60 patients...

Cite
Guarnotta V, Pillitteri G, Gambino G, et al. Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study. J Endocrinol Invest. 2020;44(7):1387-1394doi: 10.1007/s40618-020-01421-3.
Guarnotta, V., Pillitteri, G., Gambino, G., Radellini, S., Vigneri, E., Pizzolanti, G., & Giordano, C. (2021). Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study. Journal of endocrinological investigation, 44(7), 1387-1394. https://doi.org/10.1007/s40618-020-01421-3
Guarnotta, V, et al. "Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study." Journal of endocrinological investigation vol. 44,7 (2021): 1387-1394. doi: https://doi.org/10.1007/s40618-020-01421-3
Guarnotta V, Pillitteri G, Gambino G, Radellini S, Vigneri E, Pizzolanti G, Giordano C. Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study. J Endocrinol Invest. 2021 Jul;44(7):1387-1394. doi: 10.1007/s40618-020-01421-3. Epub 2020 Oct 24. PMID: 33099763; PMCID: PMC8195810.
Copy Download .nbib Format: NLM
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.

Gut

Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G.
PMID: 33436496
Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12.

OBJECTIVE: Cancer stem cells are responsible for tumour spreading and relapse. Human epidermal growth factor receptor 2 (HER2) expression is a negative prognostic factor in colorectal cancer (CRC) and a potential target in tumours carrying the gene amplification. Our...

Cite
Mangiapane LR, Nicotra A, Turdo A, et al. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut. 2021;71(1):119-128doi: 10.1136/gutjnl-2020-323553.
Mangiapane, L. R., Nicotra, A., Turdo, A., Gaggianesi, M., Bianca, P., Di Franco, S., Sardina, D. S., Veschi, V., Signore, M., Beyes, S., Fagnocchi, L., Fiori, M. E., Bongiorno, M. R., Lo Iacono, M., Pillitteri, I., Ganduscio, G., Gulotta, G., Medema, J. P., Zippo, A., Todaro, M., De Maria, R., & Stassi, G. (2022). PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut, 71(1), 119-128. https://doi.org/10.1136/gutjnl-2020-323553
Mangiapane, Laura Rosa, et al. "PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells." Gut vol. 71,1 (2022): 119-128. doi: https://doi.org/10.1136/gutjnl-2020-323553
Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12. PMID: 33436496.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries